A Single Center, Randomized, Double-blind, Parallel-design Study to Investigate the Safety and Tolerability of RO4995819 in Combination With Citalopram Following Oral Administration in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 10 Jun 2016
At a glance
- Drugs Decoglurant (Primary) ; Citalopram
- Indications Major depressive disorder
- Focus Adverse reactions
- Sponsors Roche
- 10 Jun 2016 Change in the study design, parallel assignment has been added.
- 15 Feb 2012 Actual end date changed from Oct 2011 to Jan 2012 as reported by ClinicalTrials.gov.
- 15 Nov 2011 Actual end date (October 2011) added as reported by ClinicalTrials.gov.